The National Trial Lawyers
  • Home
    • Meet Our Team
    • Contact Us
    • Mission & Goals
    • FAQ
  • Webinars
  • News
  • Membership Directory
    • Top 100 Map – Civil Plaintiff
    • Top 100 Map – Criminal Defense
    • Top 40 Under 40 Map – Civil Plaintiff
    • Top 40 Under 40 Map – Criminal Defense
  • Top 100
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Benefits
    • About
    • Top 100 President’s Message
    • Diplomat
    • Membership Renewal
    • Member Profile Updates
    • Top 100 Badge
    • Media
  • Top 40
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Top 40 Under 40 Trial Academy Bootcamp
    • Benefits
    • About
    • Top 40 President’s Message
    • Membership Renewal
    • Member Profile Updates
    • Top 40 Badge
    • Media
  • Specialty Assoc
    • About
    • Shop
    • Officers
    • Membership Renewal
    • Member Profile Updates
    • Media
  • Nominate
    • Top 100
    • Top 40
    • Specialty Association
    • Trial Lawyer Hall of Fame
    • Trial Lawyer of the Year
    • Trial Team of the Year
    • America’s Most Influential Trial Lawyer
    • America’s Most Influential Law Firm
    • Lifetime Achievement Award
  • Shop
  • Magazine
    • A-List
  • Education and Networking Agenda
    • Trial Lawyers Summit
      • Summit Sponsors
    • Top 40 Under 40 Trial Academy Boot Camp
    • Mass Torts Made Perfect
    • The Lanier Master Class 5.0 Trial Academy 2021
    • Webinars
  • Hall of Fame
    • Trial Lawyer Hall of Fame

NJ Court Affirms $11.4 Million Award in Johnson & Johnson Vaginal Mesh Suit

Posted on April 19, 2016 by Larry Bodine

prolift kitA New Jersey appeals court affirmed an $11 million damages award to a woman who claimed a defective vaginal mesh product produced by Johnson & Johnson caused unbearable nerve pain.

Defendant Johnson & Johnson was aware that the Prolift vaginal mesh could disintegrate in the vaginal wall and cause pain from the mesh arms. The court cited the company’s series of ill-considered choices for failure to include adequate safety warnings in affirming the award.

J&J ignored warning

A French physician notified the company of the defect before marketing materials were sent to doctors across the country. However Johnson & Johnson decided not to add the warnings to the label because the printing job was already at the printer.

The plaintiff, Linda Gross, had the Prolift product inserted in 2006. Her doctor described her reaction to the mesh as catastrophic.

Within two months of the surgery Gross complained of pelvic pain. After six months with the mesh, the doctor performed a second surgery to remove the mesh and found a “wrinkled bulge” and discovered that the mesh had shrunk overtime.

Physician Kevin Benson testified he trusted Johnson & Johnson to provide fair, balanced, and truthful information about Prolift. He further testified that he would not have recommended the procedure had the additional warnings were present.

Gross continued to suffer complications even after multiple surgeries for the mesh. She was unable to have an intimate relationship with her husband, lost her job as a nurse, and suffers from severe depression and anxiety.

On appeal, the defendant argued that under the intermediary doctrine the lower court erred by:

  1. Failing to bar Gross’ claim for deceit as a matter of law; and
  2. Misapplying the learned intermediary doctrine to the failure to warn claim.

Learned Intermediary Doctrine & Deceit

The learned intermediary doctrine imposes a duty on a manufacturer to warn physicians of any risks involved with its products. The physician becomes the intermediary between the manufacturer and communicates warnings to patients.

The purpose of the doctrine is to allow patients to make well-informed decisions and balance the benefits against the risk of procedures. Johnson & Johnson failed to notify the physicians of the issues until years after Gross sustained complications from the mesh.

Regarding J&J’s claim of deceit, the court stated the plaintiff is required to prove the manufacturer intentionally concealed or misrepresented of a fact which the plaintiff would rely and caused the injury.

Johnson & Johnson staff testified they were aware of the risk and issues with the Prolift before it went onto the market. But, the risk were ignored because they believed surgeons were responsible for fixing the issues.

Further, the impetus to have the product on the market and reluctance to reprint marketing materials was more important. The court held there was sufficient evidence to show Johnson & Johnson failed to inform physicians and the intermediary doctrine does not bar the deceit claim.

Failure to Warn Claim

The defendant argued the lower court erred in its jury instruction for the failure to warn claim. Johnson & Johnson stated the instructions allowed the jury to find causation based on reading the patient brochure.

There were multiple opportunities for the jury to make inferences that course of treatment for Gross would have been altered had appropriate warnings were provided.

The opinion states that Benson relied on the pamphlets and instructions for use provided with the mesh kits. Gross herself testified if all the risks, including information about multiple surgeries, chronic pain, and difficulty of removal was present, she would have declined the surgery.

The three-judge panel disagreed with the defense argument and ruled the plaintiff presented enough evidence for the jury to determine an inadequate warning was provided.

This case is Linda Gross and Jeffrey Gross v. Gynecare, Ethicon Inc, and Johnson & Johnson, Case No. A-0011-14T2, Superior Court of New Jersey

Posted in Blog, Mass Torts, Personal Injury

Comments are closed.

News Categories

Subscribe to Blog and VFJ via Email

Enter your email address to subscribe to this blog, the Voice for Justice and receive notifications of new posts by email.

Read about other Top Jury Verdicts

Toyota Will Pay $180M to Settle Violations of the Clean-Air Act

Toyota Will Pay $180M to Settle Violations of the Clean-Air Act

The U.S. Department of Justice and U.S. Environmental Protection Agency (EPA) announced today that the United States has[Read More...]
Boeing's Insitu Will Pay $25M to Settle a Whistleblower Complaint About Used Drone Parts

Boeing's Insitu Will Pay $25M to Settle a Whistleblower Complaint About Used Drone Parts

Bingen, Wash.-based Insitu, a Boeing subsidiary, has agreed to pay $25 million to settle allegations that it used recycl[Read More...]
Deutsche Bank Agrees to Settle Criminal and Civil Charges for $130M

Deutsche Bank Agrees to Settle Criminal and Civil Charges for $130M

DEUTSCHE Bank AG agreed to pay US$130 million to settle criminal and civil charges that it bribed foreign officials and manip[Read More...]
Boeing Pays $2.5B to Settle Charges Tied to the 737 MAX Crashes

Boeing Pays $2.5B to Settle Charges Tied to the 737 MAX Crashes

Boeing has agreed to pay just over $2.5 billion to resolve a federal charge of “criminal misconduct” for how its [Read More...]
Texas Attorney General Seeks $43M in Google Antitrust Lawsuit

Texas Attorney General Seeks $43M in Google Antitrust Lawsuit

The mass exodus of Texas Attorney General Ken Paxton's top staff over accusations of bribery against their former boss has le[Read More...]

#LegalNews

@@TheNTLtop100

Contact Us | Terms of Use | Privacy Policy

Attorney information and content provided on this website is provided for the benefit of members of The National Trial Lawyers and as a public service by Legal Associations Management, Inc. The website and all data are the property of Legal Associations Management, Inc. Data, including without limitation attorney information and content, on the site may not be mined, sold, or used commercially for any purpose without the explicit written consent of Legal Associations Management, Inc. This site may not be accessed by any automated program for extracting data for any use. By accessing and using the site you agree that you will not develop, support or use software, devices, scripts, robots, or any other means or processes (including crawlers, browser plug-ins and add-ons, or any other technology) to scrape data or otherwise copy profiles and other data. Unauthorized use or attempted unauthorized use of this system may subject you to both civil and criminal penalties.